Child mortality following standard, medium or high titre measles immunization in West Africa

International Journal of Epidemiology

Volumn 25, Issue 3, 1996, Pages 665-673

  Knudsen, Kim Mark ^a,b   Aaby, Peter ^a,c   Whittle, Hilton ^d   Rowe, Mary ^d   Samb, Badara ^c   Simondon, Francois ^c   Sterne, Jonathan ^e   Fine, Paul ^e  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Childhood mortality; Combined analysis; High titre measles vaccines; Measles; Sex specific mortality; Vaccine safety

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD DEATH; CHILDHOOD MORTALITY; CLINICAL TRIAL; DRUG FATALITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GAMBIA; GUINEA-BISSAU; HAITI; HUMAN; INFANT; MALE; MEASLES; MEASLES VACCINATION; MULTICENTER STUDY; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SENEGAL; SEX DIFFERENCE; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

AFRICA; AFRICA SOUTH OF THE SAHARA; CHILD HEALTH; CHILD HEALTH SERVICES; CHILD MORTALITY; CHILD SURVIVAL; COMPARATIVE STUDIES; DELIVERY OF HEALTH CARE; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; ENGLISH SPEAKING AFRICA; FRENCH SPEAKING AFRICA; GAMBIA; GUINEA-BISSAU; HEALTH; HEALTH SERVICES; IMMUNIZATION; LENGTH OF LIFE; MATERNAL-CHILD HEALTH SERVICES; MEASLES--PREVENTION AND CONTROL; MORTALITY; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PORTUGUESE SPEAKING AFRICA; PRIMARY HEALTH CARE; RESEARCH METHODOLOGY; RESEARCH REPORT; SENEGAL; SEX FACTORS; STUDIES; SURVIVORSHIP; VACCINES; VIRAL DISEASES; WESTERN AFRICA;

AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; GAMBIA; GUINEA-BISSAU; HUMANS; IMMUNIZATION; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RANDOMIZED CONTROLLED TRIALS; SENEGAL; SEX DISTRIBUTION;

CHILD MORTALITY; DEVELOPING REGION; IMMUNISATION IMPACT; IMMUNISATION PROGRAMME; MEASLES; VACCINATION; VACCINATION STRATEGY;

AFRICA, (WEST);

EID: 0029662547     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.3.665     Document Type: Article

References (26)

1. Aaby P, Knudsen K, Jensen T G et al. Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990; 162: 1043-48.
2. Whittle H, Hanlon P, O'Neill K et al. Trial of high-dose Edmonston-Zagreb measles vaccine in The Gambia: Antibody response and side-effects. Lancet 1988; ii: 811-14.
3. Tidjani O, Grunitsky B, Guerin N et al. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet 1989; ii: 1357-60.
4. Markowitz L E, Sepulveda J, Diaz-Ortega J L et al. Immunization of six months old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med 1990; 322: 580-87.
5. Whittle H C, Campbell H, Rahman S, Armstrong J R M. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Lancet 1990; 336: 1046-48.
6. Whittle H C, Mann G, Eccles M et al. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1988; i: 963-66.
7. Expanded Programme on Immunization. Global Advisory Group. WHO Weekly Epidem Rec 1990; 65: 6-11.
8. Aaby P, Jensen T G, Hansen H L et al. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: Protective efficacy. Lancet 1988; ii: 809-11.
9. Aaby P, Knudsen K, Whittle H et al. Long-term survival after Edmonston-Zagreb measles vaccination: Increased female mortality. J Pediatr 1993; 122: 904-08.
10. Garenne M, Leroy O, Beau J P, Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991; 338: 903-07.
11. Aaby P, Samb B, Simondon F et al. Child mortality after high-titre measles vaccines in Senegal: the complete data set. Lancet 1991; 338: 1518.
12. Samb B, Aaby P, Whittle H, Coll Seck A, Simondon F. Protective efficacy of high titre measles vaccines administered from the age of five months in rural Senegal. Trans Ray Soc Trop Med Hyg 1993; 87: 697-701.
13. Aaby P, Samb B, Simondon F et al. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bull World Health Organ 1994; 72: 761-70.
14. Expanded Programme on Immunization. Safety and efficacy of high titre measles vaccine at 6 months of age. Weekly Epidemiol Rec 1991; 66: 249-51.
15. Halsey N. Increased mortality following high titre measles vaccines: Too much of a good thing. Pediatr Inf Dis 1993; 12: 462-65.
16. Holt E, Moulton L H, Siberry G K, Halsey N. Differential mortality by measles vaccine titre and sex. J Infect 1993; 168: 1087-96.
17. Expanded Programme on Immunization. Consultation on studies involving high titre measles vaccines. Weekly Epidemiol Rec 1992; 67: 357-61.
18. World Health Organization. Expanded Programme on Immunization. WHO EPI/RD/91.2, 1991.
19. León E L, Ward B, Kanashiro R et al. Immunologic parameters 2 years after high-titre measles immunization in Peruvian children. J Infect 1993; 168: 1097-104.
20. Aaby P, Lisse I M, Whittle H et al. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up. Epidemiol Infect 1994; 112: 413-20.
21. Cox D R, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
22. Berlin J A, Laird N M, Sacks H S, Chalmers T C. A comparison of statistical methods for combining events rates from clinical trials. Stat Med 1989; 8: 141-52.
23. Diaz-Ortega J L, Luna-Abascal M, Valdespino J L, Sepulveda J, Markowitz L E, Zell E R. Mortality and morbidity after high titre measles vaccine in Mexico. Lancet 1992; 340: 924.
24. Aaby P, Samb B, Simondon F et al. Divergent mortality for male and female recipients of low-titre and high-titre measles vaccines in rural Senegal. Am J Epidemiol 1993; 138: 746-55.
25. Aaby P, Bukh J, Lisse I M, Smits A J. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984; 8: 13-21.
26. Holt E, Boulos R, Halsey N, Boulos L M, Boulos C. Childhood survival in Haiti: The protective effect of measles vaccination. Pediatrics 1990; 85: 188-94.